Cytokinetics | CYTK - Ebit

Stock Price
68.31
Daily Change
0.05 0.07%
Monthly
8.10%
Yearly
46.43%
Q1 Forecast
65.83

Cytokinetics reported $-166.76M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Acadia Pharmaceuticals USD 35.76M 3.38M Sep/2025
Amgen USD 3.96B 464M Dec/2025
Arca Biopharma USD -25.09M 5.23M Mar/2025
Bayer EUR -399M 363M Sep/2025
Biogen USD 659.6M 157M Sep/2025
Brainstorm Cell Therapeutics USD -3.09M 100K Mar/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Capricor Therapeutics USD -24.98M 17.28M Mar/2025
Cytokinetics USD -166.76M 55.25M Sep/2025
Eisai JPY 20.03B 6.36B Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Exelixis USD 235.91M 20.45M Dec/2025
Geron USD -13.89M 1.43M Sep/2025
Halozyme Therapeutics USD -88.41M 306.33M Dec/2025
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
Ligand Pharmaceuticals USD 158.89M 115.32M Sep/2025
Merck USD 6.24B 1.32B Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
Pfizer USD 4.65B 71M Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025